Stroke

Cardiovascular departments are playing a role in stroke interventions at numerous health systems, working as part of the stroke care team with neurologists, radiology and the emergency department. Stroke first has be be classified as ischemic or hemorrhagic. These have very different care pathways. Ischemic strokes are increasingly being treated with neurological-interventional therapy that includes catheter based mechanical thrombectomy to remove the clot. This is a more aggressive treatment compared to traditional IV administration of tissue plasminogen activator (tPA) thrombolytic therapy to dissolve the clot. Subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH) brain bleeds can also be treated in some cases stent flow diverters and embolization coils.

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference
Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates.
How the shape, size and location of calcified carotid plaques affect stroke risk
A new analysis provides further insight into factors affecting plaque stability and subsequent ischemic events
A closer look at world’s first TAVR patient treated with new cerebral embolic protection device
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.
Cannabis is bad for the heart—should the risk be taken more seriously?
Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and highlighted the importance of discussing these risks with patients.
Extended CTA exams more than triple stroke detection
New research reveals that expanding CT angiography scans of the head and neck to capture the area at least 6 cm below the carina can significantly increase the detection of cardioaortic thrombi.

artificial intelligence money finance acquisition

Report: Johnson & Johnson wants to sell its stroke business for more than $1B

Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.

healthcare money economics dollar stethoscope acquire merger

Novartis to acquire drugmaker behind new heart therapy for up to $3.1B

The FDA has already shown great interest in the drug, which is designed to help AFib patients reduce their stroke and systemic embolism risks.

AI brings cardiology, neurology teams together to boost care for stroke patients

A new post-stroke care pathway from Viz.ai and Medtronic is associated with significant benefits, including higher patient and clinician satisfaction.

Post-stroke follow-up care considerably worse for women than men

Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts.

Be good to your teeth: Regular flossing reduces risk of stroke, AFib

The difference in atrial fibrillation risk was unexpected, surprising researchers.

AI uncovers ‘vascular fingerprints’ in the eye that can predict strokes

An advanced algorithm was trained to evaluate more than 100 different details about the inside of a patient's eye. Its ability to identify high-risk patients was comparable to more traditional techniques, exciting researchers.

Medtronic expands carotid portfolio with Contego Medical deal

Medtronic entered into an exclusive U.S. distribution agreement with Contego Medical for carotid and peripheral vascular disease revascularization products. The agreement includes an option to acquire the full company at a later date.

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.

Stroke

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference

How the shape, size and location of calcified carotid plaques affect stroke risk

A closer look at world’s first TAVR patient treated with new cerebral embolic protection device

Cannabis is bad for the heart—should the risk be taken more seriously?

Extended CTA exams more than triple stroke detection